PHAXIAM Therapeutics Quote - PHXM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.70

Bid

1.67

Ask

1.70

Volume

3,661

1.67 Day's Range 1.70

1.50 52 Week Range 4.75

Market Cap

52.682M

Previous Close

1.70

Open

1.684

Last Trade

1.7

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

15,540

Shares Outstanding

30,989,584

Dividend Yield

PE Ratio

-2.24

Earnings Per Share (EPS)

-0.76

Revenue

1.33M

Net Profit

-23.49M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.phaxiam.com

Headquarters

Lyon, Rhone, Fra

Founded

PHAXIAM Therapeutics SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker PHXM. The last closing price for PHAXIAM Therapeutics was 1.70 €. Over the last year, PHAXIAM Therapeutics shares have traded in a share price range of 1.50 € to 4.75 €.

PHAXIAM Therapeutics currently has 30,989,584 shares outstanding. The market capitalization of PHAXIAM Therapeutics is 52.68 € million. PHAXIAM Therapeutics has a price to earnings ratio (PE ratio) of -2.24.

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024 Article 223-16 of general regulation of French...

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024 Article 223-16 du Règlement Général de...

PHAXIAM présente une stratégie de développement ambitieuse pour tirer parti de l'évolution rapide du marché de la phagothérapie

PHAXIAM présente une stratégie de développement ambitieuse pour tirer parti de l'évolution rapide du marché de la phagothérapie Tenue d’un webinaire le 27 novembre 2024 « Evolving strategic...

PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area

PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area Webinar being held today "Evolving strategic context for phages...

PHAXIAM a présenté son test IVD Phagogramme et l’actualisation du suivi de sensibilité à ses phages lors du premier « Phagogram Day »

PHAXIAM a présenté son test IVD Phagogramme et l’actualisation du suivi de sensibilité à ses phages lors du premier « Phagogram Day » PHAXIAM a présenté son test IVD Phagogramme et l’actualisation...

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024 Information mensuelle relative au nombre total de droits de vote et...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.002	-0.117508813161	1.702	1.76	1.67	7767	1.72274089	DE
4	0.13	8.28025477707	1.57	1.78	1.5	9918	1.69417455	DE
12	-0.05	-2.85714285714	1.75	2.145	1.5	15540	1.7583876	DE
26	-0.3	-15	2	2.31	1.5	10776	1.8063788	DE
52	-2.805	-62.2641509434	4.505	4.75	1.5	8741	2.24492815	DE
156	0.91	115.189873418	0.79	6	0.353	25709	1.1961676	DE
260	0.91	115.189873418	0.79	6	0.353	25709	1.1961676	DE

PHXM - Frequently Asked Questions (FAQ)

What is the current PHAXIAM Therapeutics share price?

The current share price of PHAXIAM Therapeutics is 1.70 €

How many PHAXIAM Therapeutics shares are in issue?

PHAXIAM Therapeutics has 30,989,584 shares in issue

What is the market cap of PHAXIAM Therapeutics?

The market capitalisation of PHAXIAM Therapeutics is EUR 52.68M

What is the 1 year trading range for PHAXIAM Therapeutics share price?

PHAXIAM Therapeutics has traded in the range of 1.50 € to 4.75 € during the past year

What is the PE ratio of PHAXIAM Therapeutics?

The price to earnings ratio of PHAXIAM Therapeutics is -2.24

What is the cash to sales ratio of PHAXIAM Therapeutics?

The cash to sales ratio of PHAXIAM Therapeutics is 39.72

What is the reporting currency for PHAXIAM Therapeutics?

PHAXIAM Therapeutics reports financial results in EUR

What is the latest annual turnover for PHAXIAM Therapeutics?

The latest annual turnover of PHAXIAM Therapeutics is EUR 1.33M

What is the latest annual profit for PHAXIAM Therapeutics?

The latest annual profit of PHAXIAM Therapeutics is EUR -23.49M

What is the registered address of PHAXIAM Therapeutics?

The registered address for PHAXIAM Therapeutics is 60 AVENUE ROCKEFELLER, LYON, RHONE, 69008

What is the PHAXIAM Therapeutics website address?

The website address for PHAXIAM Therapeutics is www.phaxiam.com

Which industry sector does PHAXIAM Therapeutics operate in?

PHAXIAM Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EIFDSTour Eiffel DS	0.0432 € (800.00%)	89.74k
SEQUASequana medical NV	2.76 € (33.33%)	1.64M
ALEUPEuroplasma	0.0484 € (28.38%)	6.54M
ALPAUPaulic Meunerie SA	1.43 € (16.26%)	17.14k
GNROGeNeuro SA	0.081 € (15.38%)	330.33k
MLSMLSmalto	0.0125 € (-32.43%)	50
ALVIAVialife Sa	13.30 € (-27.72%)	7
MLMADMade	9.25 € (-15.91%)	255
ALALOAcheterLouerFR	0.23 € (-14.81%)	3.92k
ALLPLLepermislibre SA	0.397 € (-11.78%)	3.01k
ATOAtos SE	0.0023 € (-4.17%)	396.59M
BCPBanco Comercial Portugues SA	0.451 € (0.16%)	17.85M
LATLatecoere	0.0094 € (3.30%)	9.13M
ALVERVergnet	0.0021 € (-4.55%)	8.37M
ALEUPEuroplasma	0.0484 € (28.38%)	6.54M